- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypercholesterolaemia
- Meeting Date: July 2022
- Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 189KB)
Evolocumab – July 2022
Evolocumab: Injection 140 mg in 1 mL single use pre-filled pen, Injection 420 mg in 3.5 mL single use pre-filled cartridge; Repatha®
Last updated
28 October 2022